glp 1 news The GLP-1 revolution: What UAB researchers are discovering about how these drugs work GLP-1 Pipeline Update: May 2026

From a weight-inclusive perspective, the goal is not to shame or glorify these drugs, but to center informed consent, body autonomy, and holistic well-being

But beneath the hype and fear is a simple story: these drugs target a core metabolic signaling pathway that influences cardiovascular health, inflammation, cognition, kidney function, and long-term resilience

We saw not only was there weight loss, but we saw even further reduction of the AHI

Theyre expensive

144147 Triple agonist Triple agonists go even further

Information Type Research Article Information European Psychiatry , Volume 66 , Issue 1 , 2023 , e99 Creative Commons This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence ( which permits unrestricted re-use, distribution and reproduction, provided the original article is properly cited